Dataset Information


Combined Salvianolic Acid B and Ginsenoside Rg1 Exerts Cardioprotection against Ischemia/Reperfusion Injury in Rats.

ABSTRACT: Lack of pharmacological strategies in clinics restricts the patient prognosis with myocardial ischemia/reperfusion (I/R) injury. The aim of this study was to evaluate the cardioprotection of combined salvianolic acid B (SalB) and ginsenoside Rg1 (Rg1) against myocardial I/R injury and further investigate the underlying mechanism. I/R injury was induced by coronary artery ligation for Wistar male rats and hypoxia/reoxygenation injury was induced on H9c2 cells. Firstly, the best ratio between SalB and Rg1was set as 2:5 based on their effects on heart function detected by hemodynamic measurement. Then SalB-Rg1 (2:5) was found to maintain mitochondrial membrane potential and resist apoptosis and necrosis in H9c2 cell with hypoxia/reoxygenation injury. Companying with same dose of SalB or Rg1 only, SalB-Rg1 showed more significant effects on down-regulation of myocardial infarct size, maintenance of myocardium structure, improvement on cardiac function, decrease of cytokine secretion including TNF-?, IL-1?, RANTES and sVCAM-1. Finally, the SalB-Rg1 improved the viability of cardiac myocytes other than cardiac fibroblasts in rats with I/R injury using flow cytometry. Our results revealed that SalB-Rg1 was a promising strategy to prevent myocardial I/R injury.


PROVIDER: S-EPMC4539231 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4691119 | BioStudies
2018-01-01 | S-EPMC5808323 | BioStudies
2018-01-01 | S-EPMC5960613 | BioStudies
2019-01-01 | S-EPMC6535818 | BioStudies
2020-01-01 | S-EPMC7052384 | BioStudies
2020-01-01 | S-EPMC7399766 | BioStudies
2020-01-01 | S-EPMC7348154 | BioStudies
2017-01-01 | S-EPMC5638850 | BioStudies
2015-01-01 | S-EPMC4562266 | BioStudies
2015-01-01 | S-EPMC4383534 | BioStudies